These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417 [TBL] [Abstract][Full Text] [Related]
30. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902 [TBL] [Abstract][Full Text] [Related]
31. Challenges in HSV encephalitis: normocellular CSF, unremarkable CCT, and atypical MRI findings. Bewersdorf JP; Koedel U; Patzig M; Dimitriadis K; Paerschke G; Pfister HW; Klein M Infection; 2019 Apr; 47(2):267-273. PubMed ID: 30506479 [TBL] [Abstract][Full Text] [Related]
32. Outcome of herpes simplex encephalitis in children. Hsieh WB; Chiu NC; Hu KC; Ho CS; Huang FY J Microbiol Immunol Infect; 2007 Feb; 40(1):34-8. PubMed ID: 17332904 [TBL] [Abstract][Full Text] [Related]
33. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428 [TBL] [Abstract][Full Text] [Related]
34. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Raschilas F; Wolff M; Delatour F; Chaffaut C; De Broucker T; Chevret S; Lebon P; Canton P; Rozenberg F Clin Infect Dis; 2002 Aug; 35(3):254-60. PubMed ID: 12115090 [TBL] [Abstract][Full Text] [Related]
35. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M; Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966 [TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus-1 encephalitis: a review of current disease management with three case reports. Skelly MJ; Burger AA; Adekola O Antivir Chem Chemother; 2012 Sep; 23(1):13-8. PubMed ID: 23018202 [TBL] [Abstract][Full Text] [Related]
37. [Clinical characteristics of relapsing virus encephalitis and mechanisms of relapse]. Huang Y; Liu XQ; Yang YC; Gao J Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2183-6. PubMed ID: 19080667 [TBL] [Abstract][Full Text] [Related]
38. Relapse of herpes encephalitis after acyclovir therapy: report of two new cases and review of the literature. Valencia I; Miles DK; Melvin J; Khurana D; Kothare S; Hardison H; Legido A Neuropediatrics; 2004 Dec; 35(6):371-6. PubMed ID: 15627947 [TBL] [Abstract][Full Text] [Related]
39. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. Strupp M; Zingler VC; Arbusow V; Niklas D; Maag KP; Dieterich M; Bense S; Theil D; Jahn K; Brandt T N Engl J Med; 2004 Jul; 351(4):354-61. PubMed ID: 15269315 [TBL] [Abstract][Full Text] [Related]
40. Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis. Poissy J; Wolff M; Dewilde A; Rozenberg F; Raschilas F; Blas M; Georges H; Chaffaut C; Yazdanpanah Y Clin Microbiol Infect; 2009 Jun; 15(6):560-4. PubMed ID: 19392906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]